Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Bioreactors Market Value Growth And Long-Term Outlook
The bioreactors market has experienced substantial expansion in recent times. This market is projected to expand from $10.61 billion in 2025 to $12.2 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 15.0%. Historically, this growth can be attributed to factors such as the increased production of biologics, the rise of fermentation-based manufacturing, the growing adoption of fed-batch processes, increased investment in biopharma R&D, and the availability of advanced bioprocess control systems.
The bioreactors market is projected to expand significantly in the coming years, with its size expected to reach $21.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.6%. This anticipated growth during the forecast period is driven by factors such as an escalating demand for high-yield bioprocessing, the expansion of personalized medicine manufacturing, increasing integration of AI-driven process optimization, a heightened focus on production efficiency, and the broader adoption of continuous manufacturing models. Noteworthy trends anticipated in this period include the increased embrace of automated bioreactor systems, a rising utilization of continuous bioprocessing technologies, growing requirements for scalable bioreactor platforms, the proliferation of single-use bioreactor solutions, and an enhanced emphasis on process monitoring and control.
Get A Free Sample Report With In-Depth Market Insights:
Bioreactors Market Development Factors: What’s Supporting Demand?
The expanding need for biopharmaceuticals is anticipated to fuel the expansion of the bioreactors market in the coming years. Biopharmaceuticals are medical products sourced from biological origins, including proteins, cells, and living organisms, utilized for the prevention, treatment, or management of diverse illnesses. This rising demand stems from breakthroughs in medical research, the rise of personalized medicine, and the requirement for novel treatments, resulting in enhanced global healthcare outcomes. Bioreactors prove beneficial for biopharmaceuticals by facilitating the efficient and scalable manufacturing of therapeutic products, guaranteeing uniform quality, lowering production expenses, and aiding in the creation of innovative, life-improving medications. As an illustration, in November 2025, the Organisation for Economic Co operation and Development, a France-based intergovernmental economic organization, indicated that the average per capita spending on retail pharmaceuticals stood at USD 766 (adjusted for purchasing power disparities) across OECD countries in 2023. Consequently, the growing need for biopharmaceuticals is stimulating the expansion of the bioreactors market.
Bioreactors Market Breakdown By Product Type And Application
The bioreactors market covered in this report is segmented –
1) By Type Of Bioprocess: Batch And Fed-Batch, Continuous
2) By Cell: Mammalian Cells, Bacterial Cells, Yeast Cells, Other Cells
3) By Control: Manual, Automated
4) By Usage: Lab Scale Production, Pilot Scale Production, Full Scale Production
5) By End-Use: Research And Development (R&D) Organizations, Biopharmaceutical (Biopharma) Manufacturers, Contract Manufacturing Organizations (CMOS)
Subsegments:
1) By Batch And Fed-Batch: Traditional Batch Bioreactors, Fed-Batch Bioreactors
2) By Continuous: Perfusion Bioreactors, Continuous Stirred Tank Bioreactors (CSTR)
Bioreactors Market Transformation Trends: What Innovations Are Driving Change?
Leading companies in the bioreactors market are concentrating on developing advanced products, such as fixed-bed bioreactors, to support the cultivation of more complex biological cultures. A fixed-bed bioreactor is a type of bioreactor where biological organisms are attached to a solid support, which is typically composed of porous materials like beads, fibers, or granules. This design improves mass transfer, minimizes shear stress, and provides enhanced control over the biological processes. For instance, in October 2024, Univercells Technologies, a biotechnology company based in Belgium, launched the Scale-X Nexo bioreactor. This innovative bioreactor, featuring a 0.5 m² growth surface, is specifically designed to optimize cell culture process development, offering substantial benefits for biopharmaceutical companies and research institutions. The Scale-X Nexo enables seamless scalability to larger models, reduces media and reagent consumption, and has the potential to lower operational costs by up to 60% compared to traditional entry-level bioreactors. Additionally, its integration with the Skaia Vision application software further boosts productivity by providing precise cell count estimations without the need for direct sampling.
Bioreactors Market Company Landscape And Competitive Strategy
Major companies operating in the bioreactors market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Cytiva Bioscience Holding Ltd., Sartorius AG, Cellexus Ltd., Getinge AB, Eppendorf AG, ZETA Holding, Pierre Guerin, PBS Biotech Inc., TAP Biosystems, BBI-Biotech GmbH, HiTec Zang GmbH, Bioengineering AG, Infors AG, Univercells Technologies SA, CerCell A/S, Bailun Biotechnology Co. Ltd., BioNet, Shanghai Ritai Medicine Equipment Project Co. Ltd.
View The Full Bioreactors Market Report:
Bioreactors Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the bioreactors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioreactors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









